Biomedical Applications of Polyurethanes: A Review of Past Promises, Present Realities, and a Vibrant Future

Polyurethanes, having extensive structure/property diversity, are one of the most bio- and blood-compatible materials known today. These materials played a major role in the development of many medical devices ranging from catheters to total artificial heart. Properties such as durability, elasticity, elastomer-like character, fatigue resistance, compliance, and acceptance or tolerance in the body during the healing, became often associated with polyurethanes. Furthermore, propensity for bulk and surface modification via hydrophilic/hydrophobic balance or by attachments of biologically active species such as anticoagulants or biorecognizable groups are possible via chemical groups typical for polyurethane structure. These modifications are designed to mediate and enhance the acceptance and healing of the device or implant. Many innovative processing technologies are used to fabricate functional devices, feeling and often behaving like natural tissue. The hydrolytically unstable polyester polyurethanes were replaced by more resistant but oxidation-sensitive polyether polyols based polyurethanes and their clones containing silicone and other modifying polymeric intermediates. Chronic in vivo instability, however, observed on prolonged implantation, became a major roadblock for many applications. Presently, utilization of more oxidation resistant polycarbonate polyols as soft segments, in combination with antioxidants such as Vitamin E, offer materials which can endure in the body for several years. The applications cover cardiovascular devices, artificial organs, tissue replacement and augmentation, performance enhancing coatings and many others. In situ polymerized, cross-linked systems could extend this biodurability even further. The future will expand this field by revisiting chemically-controlled biodegradation, in combination with a mini-version of RIM technology and minimally invasive surgical procedures, to form, in vivo, a scaffold, by delivery of reacting materials to the specific site in the body and polymerizing the mass in situ. This scaffold will provide anchor for tissue regeneration via cell attachment, proliferation, control of inflammation, and healing.

[1]  L. Morbitzer,et al.  Correlations between chemical structure, stress‐induced crystallization, and deformation behavior of polyurethane elastomers , 1972 .

[2]  C. S. Schollenberger,et al.  Thermoplastic Polyurethane Elastomer Melt Polymerization Study , 1982 .

[3]  Stuart L. Cooper,et al.  Effect of segment size and polydispersity on the properties of polyurethane block polymers , 1973 .

[4]  D. Lyman,et al.  New synthetic membranes for dialysis. IV. A copolyether-urethane membrane system. , 1967, Journal of biomedical materials research.

[5]  C. S. Schollenberger,et al.  Thermoplastic Urethane Chemical Crosslinking Effects , 1975 .

[6]  D. J. Dempsey,et al.  Development of an Aliphatic Biomedical-Grade Polyurethane Elastomer , 1983 .

[7]  J W Boretos,et al.  Segmented polyurethane: a polyether polymer, II. Two years experience. , 1971, Journal of biomedical materials research.

[8]  Stuart L. Cooper,et al.  Polyurethanes In Medicine , 1986 .

[9]  John W. Boretos,et al.  Past, present and future role of polyurethanes for surgical implants , 1980 .

[10]  P Couvreur,et al.  Implant Materials in Biofunction: Advances in Biomaterials 8, Editors: C. de Putter, G.L. Lange, K. de Groot and A.J.C. Lee Elsevier, Amsterdam, 1988, pp 522, DFL 365.00 , 1989 .

[11]  S D Bruck,et al.  Development of block copolyether-urethane intra-aortic balloons and other medical devices. , 1973, Journal of biomedical materials research.

[12]  D J Wheatley,et al.  New polyurethane heart valve prosthesis: design, manufacture and evaluation. , 1996, Biomaterials.

[13]  M Szycher,et al.  SPYROFLEX™: A Tryptosorbent Wound Dressing and Wound Closure , 1992, Journal of biomaterials applications.

[14]  S Furman,et al.  Retained endocardial pacemaker electrodes. , 1968, The Journal of thoracic and cardiovascular surgery.

[15]  Richard J. Zdrahala,et al.  Thermoplastic Polyurethanes Softening in 37°C N-Saline , 1985 .

[16]  Stuart L. Cooper,et al.  Properties of linear elastomeric polyurethanes , 1966 .

[17]  R. Levy,et al.  Phosphonated polyurethanes that resist calcification. , 1994, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[18]  Jiri E. Kresta,et al.  Reaction Injection Molding and Fast Polymerization Reactions , 1982 .

[19]  F. E. Critchfield,et al.  Thermoplastic urethane elastomers. III. Effects of variations in isocyanate structure , 1975 .

[20]  R J Zdrahala,et al.  Softening of Thermoplastic Polyurethanes: A Structure/Property Study , 1987, Journal of biomaterials applications.

[21]  N. Schneider,et al.  Transition behavior and phase segregation in TDI polyurethanes , 1977 .

[22]  John C. Norman,et al.  Use of a composite Biomer-butyl rubber/Biomer material to prevent transdiaphragmatic water permeation during long-term, electrically-actuated left ventricular assist device (LVAD) pumping. , 1980, Cardiovascular diseases.

[23]  H. Planck,et al.  Polyurethanes in Biomedical Engineering , 1984 .

[24]  D J Wheatley,et al.  Calcification and fatigue failure in a polyurethane heart value. , 1995, Biomaterials.

[25]  K Stokes,et al.  Polyether polyurethanes for implantable pacemaker leads. , 1982, Biomaterials.

[26]  R. M. Gerkin,et al.  Polyether Based Thermoplastic Polyurethanes Effect of the Soft Segment Molecular Weight , 1980 .

[27]  R J Zdrahala,et al.  Small Caliber Vascular Grafts. Part II: Polyurethanes Revisited , 1996, Journal of biomaterials applications.

[28]  R Kiraly,et al.  Promising results with a new textured surface intrathoracic variable volume device for LVAS. , 1981, Transactions - American Society for Artificial Internal Organs.

[29]  L Pinchuk,et al.  A review of the biostability and carcinogenicity of polyurethanes in medicine and the new generation of 'biostable' polyurethanes. , 1994, Journal of biomaterials science. Polymer edition.

[30]  R. M. Gerkin,et al.  Polyether‐based thermoplastic polyurethanes. I. Effect of the hard‐segment content , 1979 .

[31]  R E Baier,et al.  Surface and bulk characteristics of a polyether urethane for artificial hearts. , 1975, Journal of biomedical materials research.

[32]  P. Urbański,et al.  Glass wool-H2O2/CoCl2 test system for in vitro evaluation of biodegradative stress cracking in polyurethane elastomers. , 1995, Journal of biomedical materials research.

[33]  T Kolff,et al.  Copolyether-urethanes as materials for artificial hearts. , 1973, Biomaterials, medical devices, and artificial organs.

[34]  Engelbert Pechhold,et al.  A New Investigation of Tetrahydrofuran-Based Polyether Glycols in Urethane Elastomers , 1980 .

[35]  M C Davies,et al.  Uptake of drugs by catheters: the influence of the drug molecule on sorption by polyurethane catheters. , 1996, Biomaterials.

[36]  L. Martínez-Martínez,et al.  Effect of three plastic catheters on survival and growth of Pseudomonas aeruginosa. , 1990, The Journal of hospital infection.

[37]  W S Pierce,et al.  Segmented Polyurethane: A New Elastomer for Biomedical Applications , 1967, Science.

[38]  D Paul,et al.  POLYMER HOLLOW FIBER MEMBRANES FOR REMOVAL OF TOXIC SUBSTANCES FROM BLOOD , 1989 .

[39]  S. Cooper,et al.  Measurement of transient thrombus deposition on polymeric materials. , 1979, Thrombosis research.